NYSE:A - Agilent Technologies Stock Price, Forecast & News

Agilent Technologies' stock was trading at $68.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, A shares have increased by 0.1% and is now trading at $68.92. View which stocks have been mosted impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Agilent Technologies.

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for Agilent Technologies.

Agilent Technologies Inc (NYSE:A) issued its earnings results on Tuesday, February, 18th. The medical research company reported $0.81 earnings per share for the quarter, meeting analysts' consensus estimates of $0.81. The medical research company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.36 billion. Agilent Technologies had a return on equity of 20.49% and a net margin of 14.59%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.76 earnings per share. View Agilent Technologies' earnings history.

Agilent Technologies declared a quarterly dividend on Wednesday, March 18th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.18 per share on Wednesday, April 22nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Monday, March 30th. View Agilent Technologies' dividend history.

Agilent Technologies declared that its Board of Directors has authorized a share repurchase plan on Monday, November 19th 2018, which authorizes the company to buyback $1,750,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 8.8% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its stock is undervalued.

Agilent Technologies updated its FY20 earnings guidance on Tuesday, February, 18th. The company provided EPS guidance of $3.38-3.43 for the period, compared to the Thomson Reuters consensus estimate of $3.42. The company issued revenue guidance of $5.50-5.55 billion, compared to the consensus revenue estimate of $5.54 billion.

14 brokers have issued 12-month price objectives for Agilent Technologies' shares. Their forecasts range from $57.00 to $96.00. On average, they expect Agilent Technologies' share price to reach $81.92 in the next twelve months. This suggests a possible upside of 18.9% from the stock's current price. View analysts' price targets for Agilent Technologies.

Media coverage about A stock has trended somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Agilent Technologies earned a news sentiment score of 0.6 on InfoTrie's scale. They also assigned headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutAgilent Technologies.

Agilent Technologies saw a increase in short interest in March. As of March 13th, there was short interest totaling 5,679,800 shares, an increase of 12.9% from the February 27th total of 5,030,000 shares. Based on an average daily trading volume, of 2,000,000 shares, the short-interest ratio is currently 2.8 days. Currently, 1.8% of the company's stock are sold short. View Agilent Technologies' Current Options Chain.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Bruker (BRKR), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Alibaba Group (BABA), AT&T (T), Netflix (NFLX), Boeing (BA), Walt Disney (DIS), Paypal (PYPL), Gilead Sciences (GILD) and Intel (INTC).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of A stock can currently be purchased for approximately $68.92.

Agilent Technologies has a market capitalization of $21.34 billion and generates $5.16 billion in revenue each year. The medical research company earns $1.07 billion in net income (profit) each year or $3.11 on an earnings per share basis. Agilent Technologies employs 16,300 workers across the globe. View additional information about Agilent Technologies.

The official website for Agilent Technologies is http://www.agilent.com/.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected]